A simple and sensitive method for measuring tumor-specific T cell cytotoxicity
Xinping Fu, Lihua Tao, Armando Rivera, Shana Williamson, Xiao-Tong Song, Nabil Ahmed, Xiaoliu Zhang, Xinping Fu, Lihua Tao, Armando Rivera, Shana Williamson, Xiao-Tong Song, Nabil Ahmed, Xiaoliu Zhang
Abstract
A simple and sensitive method to quantitatively measure the cytolytic effect of tumor-specific T killer cells is highly desirable for basic and clinical studies. Chromium (51Cr) release assay has been the "gold standard" for quantifying cytolytic activities of cytotoxic T lymphocytes (CTLs) against target cells and this method is still being used in many laboratories. However, a major drawback of this method is the use of radioactive materials, which is inconvenient to handle because of environmental safety concerns and expensive due to the short half-life of the isotope. Consequently, several nonradioactive methods have been reported recently. Here we report a new method that we recently developed for quantifying antigen-specific cytolytic activity of CTLs. This method fully exploits the high sensitivity and the relative simplicity of luciferase quantitative assay. We initially expected the released luciferase in the supernatant to be the adequate source for monitoring cell death. However, to our total surprise, incubation of these killer T cells with the tumor cell targets did not result in significant release of luciferase in the culture medium. Instead, we found that the remaining luciferase inside the cells could accurately reflect the overall cell viability.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Harty JT, Tvinnereim AR, White DW. CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol. 2000;18:275–308.
- Nelson DL, Kurman CC, Serbousek DE. 51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC). Curr Protoc Immunol Chapter. 2001;7:Unit 7 27.
- Ayres FM, Narita M, Takahashi M, Alldawi L, Liu A, et al. A comparative study of the JAM test and 51Cr-release assay to assess the cytotoxicity of dendritic cells on hematopoietic tumor cells. Immunol Invest. 2003;32:219–227.
- Andre ND, Barbosa DS, Munhoz E, Estevao D, Cecchini R, et al. Measurement of cytotoxic activity in experimental cancer. J Clin Lab Anal. 2004;18:27–30.
- Hoppner M, Luhm J, Schlenke P, Koritke P, Frohn C. A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. J Immunol Methods. 2002;267:157–163.
- van Baalen CA, Kwa D, Verschuren EJ, Reedijk ML, Boon AC, et al. Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity. J Infect Dis. 2005;192:1183–1190.
- Chen K, Chen L, Zhao P, Marrero L, Keoshkerian E, et al. FL-CTL assay: fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells. J Immunol Methods. 2005;300:100–114.
- Nakazawa Y, Huye LE, Dotti G, Foster AE, Vera JF, et al. Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes. J Immunother. 2009;32:826–836.
- Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992;52:1399–1405.
- Wilson MH, Coates CJ, George AL., Jr PiggyBac transposon-mediated gene transfer in human cells. Mol Ther. 2007;15:139–145.
- Ahmed N, Ratnayake M, Savoldo B, Perlaky L, Dotti G, et al. Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res. 2007;67:5957–5964.
- Li X, Lobo N, Bauser CA, Fraser MJ., Jr The minimum internal and external sequence requirements for transposition of the eukaryotic transformation vector piggyBac. Mol Genet Genomics. 2001;266:190–198.
- Thompson JF, Hayes LS, Lloyd DB. Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene. 1991;103:171–177.
- Kurschus FC, Fellows E, Stegmann E, Jenne DE. Granzyme B delivery via perforin is restricted by size, but not by heparan sulfate-dependent endocytosis. Proc Natl Acad Sci U S A. 2008;105:13799–13804.
- Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, et al. Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors. Blood. 2002;100:3155–3163.
- Cohen CJ, Li YF, El-Gamil M, Robbins PF, Rosenberg SA, et al. Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res. 2007;67:3898–3903.
Source: PubMed